NIH-funded research R01 grant

Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups with Rheumatic Diseases

Official title: Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases

Funded at University of Alabama at Birmingham · NIH-11371381 · Data updated 2026-11-12

A patient-facing program tests a multi-modal approach using storytelling videos and trained patient navigators to help Black and Latinx adults with autoimmune rheumatic diseases get recommended COVID-19 vaccines and boosters.

More COVID-19 research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startAugust 17, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$1,230,473
NIH project number4R01MD019235-04
Project IDNIH-11371381 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 and older with autoimmune rheumatic diseases, who are Black or Latinx, receiving care at participating rheumatology clinics.

Less likely to help

Individuals without AIRDs or those outside the targeted geographic regions may not benefit from this specific program.

What this research studies

This project partners with communities to create relatable stories from vaccinated patients with AIRDs and uses trained navigators to guide individuals through vaccine guidelines and logistics. It will be tested in a randomized trial across rheumatology clinics in the Southern and Northeastern United States. If successful, the approach could increase vaccination completion and booster uptake among Black and Latinx adults with AIRDs.

Why it matters

Potential benefit: If successful, the intervention could lead to higher vaccination rates and better protection against COVID-19 for people with AIRDs.

How similar studies have gone: Prior community-engaged interventions with storytelling and navigation have shown promise in improving vaccine uptake in diverse populations, but results vary by disease group and setting.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Danila, Maria Ioana — University of Alabama at Birmingham
  • Study coordinator: Danila, Maria Ioana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.